World

Top 946 largest Companies in the Biotechnology industry in the World by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry in the world by market capitalization with links to their reference stock.

World Biotechnology Industry Analysis
World Top Companies World Companies Analysis

Top Biotechnology Companies in the World as of Jan. 01, 2025

Rank Company Market Cap (USD) Country Sector Industry
691 Citius Pharmaceuticals, Inc. $28.0 M United States US Healthcare US Biotechnology
692 Delta-Fly Pharma, Inc. $27.9 M Japan Japanese Healthcare Japanese Biotechnology
693 Freeline Therapeutics Holdings plc $27.6 M

(Jan. 1, 2024)

United Kingdom UK Healthcare UK Biotechnology
694 Cara Therapeutics, Inc. $27.4 M United States US Healthcare US Biotechnology
695 BioLineRx Ltd. $27.0 M Israel Israeli Healthcare Israeli Biotechnology
696 Cyclo Therapeutics, Inc. $26.9 M United States US Healthcare US Biotechnology
697 Rain Therapeutics, Inc. $26.7 M United States US Healthcare US Biotechnology
698 Ultimovacs ASA $25.9 M

(July 1, 2024)

Norway Norway Healthcare Norway Biotechnology
699 HOOKIPA Pharma Inc. $24.6 M United States US Healthcare US Biotechnology
700 Enlivex Therapeutics Ltd. $23.8 M Israel Israeli Healthcare Israeli Biotechnology
701 Biotron Limited $23.4 M

(July 1, 2024)

Australia Australian Healthcare Australian Biotechnology
702 Aprea Therapeutics, Inc. $22.8 M United States US Healthcare US Biotechnology
703 Valbiotis SA $22.2 M France French Healthcare French Biotechnology
704 PolyPid Ltd. $22.1 M Israel Israeli Healthcare Israeli Biotechnology
705 OptiBiotix Health plc $21.8 M United Kingdom UK Healthcare UK Biotechnology
706 Cocrystal Pharma, Inc. $21.5 M United States US Healthcare US Biotechnology
707 Onconova Therapeutics, Inc. $20.9 M United States US Healthcare US Biotechnology
708 Athira Pharma, Inc. $20.9 M United States US Healthcare US Biotechnology
709 Yumanity Therapeutics, Inc. $20.5 M

(Dec. 1, 2022)

United States US Healthcare US Biotechnology
710 NeuroBo Pharmaceuticals, Inc. $20.3 M United States US Healthcare US Biotechnology
711 Finch Therapeutics Group, Inc. $18.9 M United States US Healthcare US Biotechnology
712 Metacrine, Inc. $18.8 M

(Jan. 1, 2023)

United States US Healthcare US Biotechnology
713 Vascular Biogenics Ltd. $18.3 M

(July 1, 2023)

Israel Israeli Healthcare Israeli Biotechnology
714 Affimed N.V. $18.0 M Germany German Healthcare German Biotechnology
715 Acorda Therapeutics, Inc. $18.0 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology
716 Mawson Infrastructure Group, Inc. $17.8 M Australia Australian Healthcare Australian Biotechnology
717 Oncimmune Holdings plc $17.8 M United Kingdom UK Healthcare UK Biotechnology
718 GlycoMimetics, Inc. $17.6 M United States US Healthcare US Biotechnology
719 BioXcel Therapeutics, Inc. $16.9 M United States US Healthcare US Biotechnology
720 Acer Therapeutics Inc. $16.1 M

(Nov. 1, 2023)

United States US Healthcare US Biotechnology

Top Biotechnology Companies in the World as of Jan. 01, 2025

691. Citius Pharmaceuticals, Inc.

Company Profile: Citius Pharmaceuticals, Inc.
Market Cap (USD): $28.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

692. Delta-Fly Pharma, Inc.

Company Profile: Delta-Fly Pharma, Inc.
Market Cap (USD): $27.9 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Biotechnology

693. Freeline Therapeutics Holdings plc

Company Profile: Freeline Therapeutics Holdings plc
Market Cap (USD): $27.6 M (Jan. 1, 2024)
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

694. Cara Therapeutics, Inc.

Company Profile: Cara Therapeutics, Inc.
Market Cap (USD): $27.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

695. BioLineRx Ltd.

Company Profile: BioLineRx Ltd.
Market Cap (USD): $27.0 M
Country: Israel
Sector: Israeli Healthcare
Industry: Israeli Biotechnology

696. Cyclo Therapeutics, Inc.

Company Profile: Cyclo Therapeutics, Inc.
Market Cap (USD): $26.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

697. Rain Therapeutics, Inc.

Company Profile: Rain Therapeutics, Inc.
Market Cap (USD): $26.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

698. Ultimovacs ASA

Company Profile: Ultimovacs ASA
Market Cap (USD): $25.9 M (July 1, 2024)
Country: Norway
Sector: Norway Healthcare
Industry: Norway Biotechnology

699. HOOKIPA Pharma Inc.

Company Profile: HOOKIPA Pharma Inc.
Market Cap (USD): $24.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

700. Enlivex Therapeutics Ltd.

Company Profile: Enlivex Therapeutics Ltd.
Market Cap (USD): $23.8 M
Country: Israel
Sector: Israeli Healthcare
Industry: Israeli Biotechnology

701. Biotron Limited

Company Profile: Biotron Limited
Market Cap (USD): $23.4 M (July 1, 2024)
Country: Australia
Sector: Australian Healthcare
Industry: Australian Biotechnology

702. Aprea Therapeutics, Inc.

Company Profile: Aprea Therapeutics, Inc.
Market Cap (USD): $22.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

703. Valbiotis SA

Company Profile: Valbiotis SA
Market Cap (USD): $22.2 M
Country: France
Sector: French Healthcare
Industry: French Biotechnology

704. PolyPid Ltd.

Company Profile: PolyPid Ltd.
Market Cap (USD): $22.1 M
Country: Israel
Sector: Israeli Healthcare
Industry: Israeli Biotechnology

705. OptiBiotix Health plc

Company Profile: OptiBiotix Health plc
Market Cap (USD): $21.8 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

706. Cocrystal Pharma, Inc.

Company Profile: Cocrystal Pharma, Inc.
Market Cap (USD): $21.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

707. Onconova Therapeutics, Inc.

Company Profile: Onconova Therapeutics, Inc.
Market Cap (USD): $20.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

708. Athira Pharma, Inc.

Company Profile: Athira Pharma, Inc.
Market Cap (USD): $20.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

709. Yumanity Therapeutics, Inc.

Company Profile: Yumanity Therapeutics, Inc.
Market Cap (USD): $20.5 M (Dec. 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

710. NeuroBo Pharmaceuticals, Inc.

Company Profile: NeuroBo Pharmaceuticals, Inc.
Market Cap (USD): $20.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

711. Finch Therapeutics Group, Inc.

Company Profile: Finch Therapeutics Group, Inc.
Market Cap (USD): $18.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

712. Metacrine, Inc.

Company Profile: Metacrine, Inc.
Market Cap (USD): $18.8 M (Jan. 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

713. Vascular Biogenics Ltd.

Company Profile: Vascular Biogenics Ltd.
Market Cap (USD): $18.3 M (July 1, 2023)
Country: Israel
Sector: Israeli Healthcare
Industry: Israeli Biotechnology

714. Affimed N.V.

Company Profile: Affimed N.V.
Market Cap (USD): $18.0 M
Country: Germany
Sector: German Healthcare
Industry: German Biotechnology

715. Acorda Therapeutics, Inc.

Company Profile: Acorda Therapeutics, Inc.
Market Cap (USD): $18.0 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

716. Mawson Infrastructure Group, Inc.

Company Profile: Mawson Infrastructure Group, Inc.
Market Cap (USD): $17.8 M
Country: Australia
Sector: Australian Healthcare
Industry: Australian Biotechnology

717. Oncimmune Holdings plc

Company Profile: Oncimmune Holdings plc
Market Cap (USD): $17.8 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

718. GlycoMimetics, Inc.

Company Profile: GlycoMimetics, Inc.
Market Cap (USD): $17.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

719. BioXcel Therapeutics, Inc.

Company Profile: BioXcel Therapeutics, Inc.
Market Cap (USD): $16.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

720. Acer Therapeutics Inc.

Company Profile: Acer Therapeutics Inc.
Market Cap (USD): $16.1 M (Nov. 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology